These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39396258)

  • 1. Interfering with KIR and NKG2A immune checkpoint axes to unleash NK cell immunotherapy.
    Beelen NA; Valckx VTC; Bos GMJ; Wieten L
    Best Pract Res Clin Haematol; 2024 Sep; 37(3):101568. PubMed ID: 39396258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling
    Mahaweni NM; Ehlers FAI; Bos GMJ; Wieten L
    Front Immunol; 2018; 9():2848. PubMed ID: 30564241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
    Kim N; Kim HS
    Front Immunol; 2018; 9():2041. PubMed ID: 30250471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade.
    Godal R; Bachanova V; Gleason M; McCullar V; Yun GH; Cooley S; Verneris MR; McGlave PB; Miller JS
    Biol Blood Marrow Transplant; 2010 May; 16(5):612-21. PubMed ID: 20139023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microchip-Based Single-Cell Imaging Reveals That CD56dimCD57-KIR-NKG2A+ NK Cells Have More Dynamic Migration Associated with Increased Target Cell Conjugation and Probability of Killing Compared to CD56dimCD57-KIR-NKG2A- NK Cells.
    Forslund E; Sohlberg E; Enqvist M; Olofsson PE; Malmberg KJ; Önfelt B
    J Immunol; 2015 Oct; 195(7):3374-81. PubMed ID: 26320254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.
    Cheent KS; Jamil KM; Cassidy S; Liu M; Mbiribindi B; Mulder A; Claas FH; Purbhoo MA; Khakoo SI
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16981-6. PubMed ID: 24082146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
    Lin Chua H; Brahmi Z
    Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal age related change in natural killer cell receptors for MHC class I.
    Lutz CT; Moore MB; Bradley S; Shelton BJ; Lutgendorf SK
    Mech Ageing Dev; 2005; 126(6-7):722-31. PubMed ID: 15888327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors.
    Fauriat C; Ivarsson MA; Ljunggren HG; Malmberg KJ; Michaëlsson J
    Blood; 2010 Feb; 115(6):1166-74. PubMed ID: 19903900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy.
    Beelen NA; Ehlers FAI; Bos GMJ; Wieten L
    Cancer Immunol Immunother; 2023 Apr; 72(4):797-804. PubMed ID: 36261539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy.
    Zaghi E; Calvi M; Marcenaro E; Mavilio D; Di Vito C
    J Leukoc Biol; 2019 Jun; 105(6):1243-1251. PubMed ID: 30645023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
    J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial break in tolerance of NKG2A
    Rathmann S; Keck C; Kreutz C; Weit N; Müller M; Timmer J; Glatzel S; Follo M; Malkovsky M; Werner M; Handgretinger R; Finke J; Fisch P
    Bone Marrow Transplant; 2017 Aug; 52(8):1144-1155. PubMed ID: 28481352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.
    Yu J; Venstrom JM; Liu XR; Pring J; Hasan RS; O'Reilly RJ; Hsu KC
    Blood; 2009 Apr; 113(16):3875-84. PubMed ID: 19179302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.
    Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
    Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
    J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Metabolic Function and Resilience of NKG2A-Educated NK Cells.
    Highton AJ; Diercks BP; Möckl F; Martrus G; Sauter J; Schmidt AH; Bunders MJ; Körner C; Guse AH; Altfeld M
    Front Immunol; 2020; 11():559576. PubMed ID: 33101277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionally active NKG2A-expressing natural killer cells are elevated in rheumatoid arthritis patients compared to psoriatic arthritis patients and healthy donors.
    van Bijnen ST; Cossu M; Roeven MW; Jansen TL; Preijers F; Spanholtz J; Dolstra H; Radstake TR
    Clin Exp Rheumatol; 2015; 33(6):795-804. PubMed ID: 26411696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
    Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.